Skip to main content
MAYNE PHARMA GROUP LIMITED logo

MAYNE PHARMA GROUP LIMITED — Investor Relations & Filings

Ticker · MYX ISIN · AU000000MYX0 LEI · 549300VIRDEN0N4MJG59 ASX Manufacturing
Open in API
Filings indexed 1,117 across all filing types
Latest filing 2025-08-13 Major Shareholding Noti…
Country AU Australia
Listing ASX MYX

About MAYNE PHARMA GROUP LIMITED

https://www.maynepharma.com

Mayne Pharma Group Limited is a specialty pharmaceutical company focused on the development and commercialization of branded and generic medicines. The company operates through specialized segments including Women's Health and Dermatology. Its Women's Health portfolio features innovative contraceptive solutions, while the Dermatology division provides a broad range of treatments for various skin conditions. Beyond its product portfolio, the company provides contract development and manufacturing services (CDMO), leveraging proprietary drug delivery technologies to produce complex oral and topical dosage forms. The organization focuses on high-growth specialty markets, aiming to deliver differentiated therapeutic options and improve patient outcomes through technical excellence and strategic commercialization.

Recent filings

Filing Released Lang Actions
Becoming a substantial holder from MUFG 61 pages 656.1KB
Major Shareholding Notification Classification · 100% confidence The document is titled 'Form 603 Corporations Act 2001 Section 671B Notice of initial substantial holder' and details the substantial shareholding of Mitsubishi UFJ Financial Group, Inc. in Mayne Pharma Group Limited. It includes voting power percentages, relevant interests, registered holders, consideration paid, and associates. The document is a formal notification of a substantial shareholding under Australian Corporations Act requirements. It does not contain financial statements, management discussion, or earnings data. It is a notification of a major shareholding level crossing a threshold, which fits the definition of 'Major Shareholding Notification' (Code: MRQ). The document length is substantial and contains detailed annexures, confirming it is the actual notification, not just an announcement of one. Therefore, the correct classification is MRQ with high confidence.
2025-08-13 English
Becoming a substantial holder 4 pages 673.2KB
Major Shareholding Notification Classification · 100% confidence The document is a Form 603 under the Corporations Act 2001, titled 'Notice of initial substantial holder.' It details the substantial shareholding of First Sentier Group Limited and its associates in Mayne Pharma Group Ltd, including voting power, relevant interests, registered holders, consideration paid, and associates. This type of filing is a notification of a major shareholding or change in significant ownership levels, as it reports crossing a substantial holding threshold (5.03% voting power). It is not an annual report, earnings release, or any other financial report but a regulatory disclosure of shareholding. Therefore, the appropriate classification is Major Shareholding Notification (MRQ). The document length and content confirm it is the actual notification, not just an announcement or certification.
2025-08-12 English
Change in substantial holding 7 pages 565.7KB
Major Shareholding Notification Classification · 100% confidence The document is titled 'ASX Form 604' and is described as a 'Notice of change of interests of substantial holder' under the Corporations Act 2001 Section 671B. It details changes in voting power and relevant interests of a substantial shareholder, The Goldman Sachs Group, Inc., including tables of share transactions and voting power percentages. The document is a regulatory filing notifying the market and company of changes in substantial shareholdings, which aligns with the definition of Major Shareholding Notification (MRQ). The document length is over 12,000 characters and contains detailed transaction data, not just an announcement or certification. Therefore, the correct classification is MRQ with high confidence.
2025-08-05 English
Additional notice of intention to terminate from Cosette 2 pages 167.5KB
Regulatory Filings Classification · 95% confidence The document is an ASX announcement dated 5 August 2025 from Mayne Pharma regarding a notice of intention to terminate a scheme implementation deed by Cosette Pharmaceuticals. It discusses legal and contractual disputes related to termination notices and alleged breaches but does not contain financial statements, detailed financial results, or comprehensive report data. The document is relatively short (3833 characters) and serves as a regulatory announcement about ongoing legal and contractual matters rather than a full report or detailed financial disclosure. It does not fit categories like Annual Report, Interim Report, Earnings Release, or Management Reports. It is not a certification or officer attestation. The content is best classified as a Regulatory Filing (RNS) because it is a general regulatory announcement about a dispute and contractual issues without fitting into more specific categories like Legal Proceedings Report (LTR) or M&A Activity (TAR).
2025-08-04 English
Ceasing to be a substantial holder from MUFG 7 pages 255.6KB
Major Shareholding Notification Classification · 100% confidence The document is titled 'Form 605' under the Corporations Act 2001 Section 671B, which is a regulatory form used in Australia for notifying changes in substantial shareholdings. The content details the cessation of a substantial holder status by Mitsubishi UFJ Financial Group, Inc., including detailed changes in relevant interests and securities transactions. This is a notification about changes in significant share ownership levels, not a financial report or earnings release. It fits the definition of a Major Shareholding Notification (MRQ). The document length is substantial and contains detailed transaction data, confirming it is the actual notification, not just an announcement or certification.
2025-07-01 English
Ceasing to be a substantial holder 3 pages 481.9KB
Major Shareholding Notification Classification · 100% confidence The document is titled 'Form 605' and is a 'Notice of ceasing to be a substantial holder' under the Corporations Act 2001 Section 671B. It details changes in relevant interests of a substantial holder in voting securities, including dates, nature of changes, and securities affected. This type of filing is a notification about changes in significant share ownership levels, specifically ceasing to be a substantial holder. It is not a financial report, earnings release, or management report, but a regulatory notification about shareholding changes. Therefore, it fits the category of Major Shareholding Notification (MRQ). The document length and content confirm it is the actual notice, not just an announcement or certification.
2025-06-30 English

Browse filings by year

20 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.